Abbreviations: ALP = alkaline phosphatase; ALT = alanine transaminase; AST = aspartate aminotransferase; γ-GTP = γ-glutamyltransferase.
Hepatobiliary abnormalities are rather common after allogeneic hematopoietic stem cell transplantation (allo-HSCT). 1 These abnormalities have various causes, such as drug toxicity, sinusoid obstructive syndrome (SOS), GvHD, infectious diseases, total parenteral nutrition (TPN) and iron overload. The correct diagnosis of hepatobiliary abnormalities is important so as to select the most effective treatment. However, liver biopsy after allo-HSCT is considered to have significant risks. 2 Therefore, the prevalence of each type of liver dysfunction is still unclear. Out of various causes of hepatobiliary abnormalities, deposition of nutrients is underrecognized in the field of allo-HSCT, as liver biopsy is often omitted due to a risk of complications, and provisional diagnosis of hepatobiliary abnormalities can be GvHD-or drug toxicityrelated in clinical practice after allo-HSCT. However, if the cause of hepatobiliary abnormalities is the deposition of nutrients, the appropriate treatment can be different. As representative of a tissue sample of liver obtained from patients after allo-HSCT, we focused on the autopsy samples, since it is possible to assess the deposition of the nutrients in the liver retrospectively. We hypothesized that some of the patients after allo-HSCT had deposition of nutrients in the liver, and it was associated with liver dysfunction. In this study, we assessed the hepatic deposition of fat, iron and copper in 25 post-allo-HSCT autopsy cases from 2007 to 2013. This study was approved by the institutional review board of the National Cancer Center. We chose these three nutrients in this study as the technique to assess the deposition is practically available in general.
Formalin-fixed paraffin-embedded liver specimens were stained with hematoxylin and eosin, Berlin blue or rhodanine to assess fat, iron and copper deposition, respectively. The severity of the deposition was graded as follows: mild, deposition limited to 1/3 of the hepatic lobule; moderate, 1/3-2/3; and severe, 42/3. The median age at allo-HSCT was 48 years (range, 33-69). The median interval from allo-HSCT to death was 79 days (range, 5-1163). The underlying diseases were adult T-cell leukemia/lymphoma (ATLL, n = 11), acute myeloid leukemia (AML, n = 8), acute lymphoblastic leukemia (ALL, n = 3) and others (n = 3). The cause of death was GvHD-related (n = 6), infection (n = 9), relapse/progression of underlying disease (n = 5), idiopathic pneumonia syndrome (n = 2) and others (n = 3: hemophagocytosis, cholangiocarcinoma and bleeding). TPN was used for a median duration of 20 days (range, 0-168). Patients' last laboratory data are summarized in Table 1 . Fat deposition was observed in 7 patients (28%; mild, n = 5; moderate, n = 1; severe, n = 1). Iron deposition was observed in 23 patients (92%; mild, n = 8; moderate, n = 10; severe, n = 5). Minimal copper deposition was observed in 4 patients (16%). Other pathological findings in the liver included GvHD (n = 4), SOS (n = 3), malignancy (lymphoma, n = 2; cholangiocarcinoma, n = 1) and hemophagocytosis (n = 1). As shown in Figures 1a and c , aspartate aminotransferase (AST), alanine aminotransferase (ALT) and direct bilirubin (D-Bil) levels were significantly higher in patients with copper deposition compared with those without it by the Mann-Whitney test (AST, median 174.5 vs 60 IU/L; ALT, median 143.5 vs 44 IU/L; D-Bil, median 5.25 vs 1.00 mg/dL). Higher total transfusion of red blood cells after allo-HSCT was significantly associated with a higher grade of iron overload by the Jonckheere-Terpstra test, as shown in Figure 1d . There was no significant association between fat deposition and hepatobiliary abnormalities in this study. In addition, we also assessed the impact of number of deposited nutrients. However, there was no significant association between the number of deposited nutrients and hepatobiliary abnormalities.
In this study, we demonstrated that overdeposition of fat, iron and copper in the liver was commonly observed in autopsy cases after allo-HSCT. It is possible that nutrient overdeposition plays a significant role in the pathogenesis of hepatobiliary dysfunction after allo-HSCT. Nutrient overdeposition should be included in the differential diagnosis of hepatobiliary dysfunction, as treatments differ significantly depending on the underlying condition. In terms of copper deposition, one study reported its presence in conditions other than Wilson's disease. 3 Our study is the first to assess its status after allo-HSCT. Although we found copper deposition in four patients, the deposition was mild in comparison to Wilson's disease cases. Therefore, we assume that it was not a direct cause of liver dysfunction but rather a result of reduced biliary excretion of copper due to liver dysfunction. Several studies demonstrated that a significant proportion of patients had iron overload after allo-HSCT, but other than these reports few were based on liver biopsies. [4] [5] [6] Though the present study had similar findings, its ability to estimate the incidence of nutrient deposition was limited by the small sample size. In particular, there were few patients without iron deposition, which made it difficult to assess the association between iron deposition and laboratory data. Thus, more studies are needed to assess the actual incidence and its implications. In patients with nutrient overdeposition, it might be beneficial to modify nutritional support so as to reduce the burden of the deposited nutrient(s). The relevance of fat deposition should be determined in larger case series, even though there was no significant association with liver damage in this study.
In conclusion, we found that nutrient deposition in the liver was common after allo-HSCT in autopsy cases. Further studies are 
